Resultados de la búsqueda 711-720 of 12217 for Acute angle-closure glaucoma
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
... Treatment (Temozolomide) For Brain Tumors That Have Returned After Previous Treatment. Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. The ...
... treatment, while rates of disease control during Induction have not ... This clinical trial studies the effect of short-term (acute) and long-term ...
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
The purpose of this study is to establish a prospective, standardized data collection for the patients who undergo surgical treatment of progressive ...
A Vaccine (H2NVAC) Before Surgery For The Treatment Of HER2-Expressing Ductal Carcinoma In Situ. Rochester, Minn., Jacksonville, Fla. This phase Ib trial ...
The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ciloleucel ...
... treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data will be used to establish ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?